These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30385439)

  • 21. Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism.
    Fang MC; Go AS; Prasad PA; Zhou HX; Parks AL; Fan D; Portugal C; Sung SH; Reynolds K
    Thromb Res; 2022 Aug; 216():97-102. PubMed ID: 35779378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticoagulation Treatment and Outcomes of Venous Thromboembolism by Weight and Body Mass Index: Insights From the Veterans Health Administration.
    Perino AC; Fan J; Schmitt S; Guo JD; Hlavacek P; Din N; Kothari M; Pundi K; Russ C; Emir B; Turakhia MP
    Circ Cardiovasc Qual Outcomes; 2021 Nov; 14(11):e008005. PubMed ID: 34724801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute Pulmonary Embolism in Emergency Department Patients Despite Therapeutic Anticoagulation.
    Liu MY; Ballard DW; Huang J; Rauchwerger AS; Reed ME; Bouvet SC; Vinson DR
    West J Emerg Med; 2018 May; 19(3):510-516. PubMed ID: 29760849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of a transition of care pathway for low-risk patients presenting to the emergency department with venous thromboembolism.
    Baird AM; Aday AW; Sullivan AE; Street T; Barrett TW; Collins SP; Stubblefield WB; Dnp MMS; Beckman JA
    J Vasc Nurs; 2024 Sep; 42(3):208-212. PubMed ID: 39244333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospital length of stay in patients initiated on direct oral anticoagulants versus warfarin for venous thromboembolism: a real-world single-center study.
    Badreldin H
    J Thromb Thrombolysis; 2018 Jul; 46(1):16-21. PubMed ID: 29626281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism.
    Desai A; Desai A; Calixte R; Aparnath M; Hindenburg A; Salzman S; Mathew JP
    Lung; 2016 Aug; 194(4):605-11. PubMed ID: 27192990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran.
    Leung TS; Law EH
    Drug Des Devel Ther; 2015; 9():3557-69. PubMed ID: 26185422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns and Predictors of Use of Anticoagulants for the Treatment of Venous Thromboembolism Following Approval of Rivaroxaban.
    Dault R; Vanasse A; Blais L; Perreault S; Farand P; Le Templier G; Beauchesne MF
    Clin Appl Thromb Hemost; 2016 Nov; 22(8):765-771. PubMed ID: 26467323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early, real-world experience with direct oral anticoagulants in the treatment of intermediate-high risk acute pulmonary embolism.
    Santos SM; Cunha S; Baptista R; Monteiro S; Monteiro P; Gonçalves F; Pêgo M
    Rev Port Cardiol; 2017 Nov; 36(11):801-806. PubMed ID: 29126891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community-based treatment of venous thromboembolism with a low-molecular-weight heparin and warfarin.
    Hyers TM; Spyropoulos AC;
    J Thromb Thrombolysis; 2007 Dec; 24(3):225-32. PubMed ID: 17334932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of heparin lead-in in the real-world management of acute venous thromboembolism: The PREFER in VTE registry.
    Bauersachs R; Agnelli G; Gitt AK; Monreal M; Mismetti P; Willich SN; Laeis P; Fronk EM; Bramlage P; Cohen AT;
    Thromb Res; 2017 Sep; 157():181-188. PubMed ID: 28780343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence to direct oral anticoagulants for acute venous thromboembolism.
    Dronkers CEA; Lijfering WM; Teichert M; van der Meer FJM; Klok FA; Cannegieter SC; Huisman MV
    Thromb Res; 2018 Jul; 167():135-141. PubMed ID: 29843087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New anticoagulants in the management of venous thromboembolism in women.
    Piovella F; Irina Iosub D
    Thromb Res; 2015 Feb; 135 Suppl 1():S5-7. PubMed ID: 25903537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism.
    Roetker NS; Lutsey PL; Zakai NA; Alonso A; Adam TJ; MacLehose RF
    Thromb Haemost; 2018 Sep; 118(9):1637-1645. PubMed ID: 30103250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry.
    Cohen AT; Gitt AK; Bauersachs R; Fronk EM; Laeis P; Mismetti P; Monreal M; Willich SN; Bramlage P; Agnelli G; Prefer In Vte Scientific Steering Committee And The Prefer In Vte Investigators OBOT
    Thromb Haemost; 2017 Jun; 117(7):1326-1337. PubMed ID: 28405675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-Hospital Management and Follow-Up Treatment of Venous Thromboembolism: Focus on New and Emerging Treatments.
    Lenchus JD; Biehl M; Cabrera J; Moraes AG; Dezfulian C
    J Intensive Care Med; 2017 Jun; 32(5):299-311. PubMed ID: 27179058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
    Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
    Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outpatient treatment of emergency department patients diagnosed with venous thromboembolism.
    Stubblefield WB; Kline JA
    Postgrad Med; 2021 Aug; 133(sup1):11-19. PubMed ID: 33840338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anticoagulation in Venous Thromboembolism: How Long and Which Dose?].
    Machado M; Ruosch-Girsberger S; Hegglin A; Wuillemin WA
    Praxis (Bern 1994); 2020; 109(4):270-276. PubMed ID: 32183654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter Implementation of a Novel Management Protocol Increases the Outpatient Treatment of Pulmonary Embolism and Deep Vein Thrombosis.
    Kabrhel C; Rosovsky R; Baugh C; Connors J; White B; Giordano N; Torrey J; Deadmon E; Parry BA; Hagan S; Zheng H
    Acad Emerg Med; 2019 Jun; 26(6):657-669. PubMed ID: 30341928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.